Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy

BACKGROUND. Neutrophil‐lymphocyte ratio (NLR) is a measure of systemic inflammation that appears prognostic in localized and advanced non‐small cell lung cancer (NSCLC). Increased systemic inflammation portends a poorer prognosis in cancer patients. We hypothesized that low NLR at diagnosis is assoc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Scilla, Katherine A., Bentzen, Søren M., Lam, Vincent K., Mohindra, Pranshu, Nichols, Elizabeth M., Vyfhuis, Melissa A., Bhooshan, Neha, Feigenberg, Steven J., Edelman, Martin J., Feliciano, Josephine L.
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2017
Matèries:
Lung Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5469587/
https://ncbi.nlm.nih.gov/pubmed/28533476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0443
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars